Document is current
Any future updates will be listed below
-
Authors
Haddad, Tariq Sami
Bokhorst, John-Melle
van den Dobbelsteen, Luuk
Öztürk, Sonay K.
Baumann, Elias
van Vliet, Shannon
Verrijp, Kiek
Jamieson, Nigel B
Wood, Colin
Berger, Martin D.
Kirsch, Richard
Aben, Marco
Rutgers, Natasja
Ueno, Hideki
Ciompi, Francesco
Simmer, Femke
van der Laak, Jeroen
Lugli, Alessandro
Zlobec, Inti
Nagtegaal, Iris
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (10602/2016-2)
- License Information
-
More Information
Article History
Received: 20 November 2024
Accepted: 2 May 2025
First Online: 15 May 2025
Declarations
:
: JvdL was a member of the advisory boards of Philips, the Netherlands and ContextVision, Sweden, and received research funding from Philips, the Netherlands, ContextVision, Sweden, and Sectra, Sweden in the last five years. He is chief scientific officer (CSO) and shareholder of Aiosyn BV, the Netherlands. FC was Chair of the Scientific and Medical Advisory Board of TRIBVN Healthcare, France, and received advisory board fees from TRIBVN Healthcare, France in the last five years. He is shareholder of Aiosyn BV, the Netherlands. All other authors declare no conflict of interest.
